Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

180.21
Delayed Data
As of Jul 21
 +0.89 / +0.50%
Today’s Change
133.64
Today|||52-Week Range
184.21
+23.25%
Year-to-Date

Today’s Trading

Previous close179.32
Today’s open179.26
Day’s range179.16 - 180.55
Volume2,674,714
Average volume (3 months)3,623,010
Market cap$132.5B
Dividend yield2.55%
Data as of 07/21/2017

Growth & Valuation

Earnings growth (last year)+13.02%
Earnings growth (this year)+7.18%
Earnings growth (next 5 years)+4.58%
Revenue growth (last year)+6.31%
P/E ratio17.1
Price/Sales4.86
Price/Book4.45

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+0.34+0.46%
BIIBBiogen+1.48+0.53%
ILMNIllumina Inc+0.78+0.45%
BIVVBioverativ Inc+0.44+0.70%
Data as of 07/21/2017

Financials

Next reporting dateJuly 26, 2017
EPS forecast (this quarter)$3.10
Annual revenue (last year)$22.7B
Annual profit (last year)$7.7B
Net profit margin34.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts